Melatonin Rescued Reactive Oxygen Species-Impaired Osteogenesis of Human Bone Marrow Mesenchymal Stem Cells in the Presence of Tumor Necrosis Factor-Alpha

Joint Authors

Lian, Chengjie
Gao, Bo
Wu, Zizhao
Qiu, Xianjian
Wang, Xudong
Qiu, Jincheng
Zhu, Yuanxin
Liang, Tongzhou
Peng, Yan
Liang, Anjing
Su, Peiqiang
Huang, Dongsheng

Source

Stem Cells International

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-09-05

Country of Publication

Egypt

No. of Pages

11

Abstract EN

Accumulation of reactive oxygen species (ROS), which can be induced by inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), can significantly inhibit the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).

This process can contribute to the imbalance of bone remodeling, which ultimately leads to osteoporosis.

Therefore, reducing the ROS generation during osteogenesis of BMSCs may be an effective way to reverse the impairment of osteogenesis.

Melatonin (MLT) has been reported to act as an antioxidant during cell proliferation and differentiation, but its antioxidant effect and mechanism of action during osteogenesis of MSCs in the inflammatory microenvironment, especially in the presence of TNF-α, remain unknown and need further study.

In our study, we demonstrate that melatonin can counteract the generation of ROS and the inhibitory osteogenesis of BMSCs induced by TNF-α, by upregulating the expression of antioxidases and downregulating the expression of oxidases.

Meanwhile, MLT can inhibit the phosphorylation of p65 protein and block the degradation of IκBα protein, thus decreasing the activity of the NF-κB pathway.

This study confirmed that melatonin can inhibit the generation of ROS during osteogenic differentiation of BMSCs and reverse the inhibition of osteogenic differentiation of BMSCs in vitro, suggesting that melatonin can antagonize TNF-α-induced ROS generation and promote the great effect of osteogenic differentiation of BMSCs.

Accordingly, these findings provide more evidence that melatonin can be used as a candidate drug for the treatment of osteoporosis.

American Psychological Association (APA)

Qiu, Xianjian& Wang, Xudong& Qiu, Jincheng& Zhu, Yuanxin& Liang, Tongzhou& Gao, Bo…[et al.]. 2019. Melatonin Rescued Reactive Oxygen Species-Impaired Osteogenesis of Human Bone Marrow Mesenchymal Stem Cells in the Presence of Tumor Necrosis Factor-Alpha. Stem Cells International،Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1209284

Modern Language Association (MLA)

Qiu, Xianjian…[et al.]. Melatonin Rescued Reactive Oxygen Species-Impaired Osteogenesis of Human Bone Marrow Mesenchymal Stem Cells in the Presence of Tumor Necrosis Factor-Alpha. Stem Cells International No. 2019 (2019), pp.1-11.
https://search.emarefa.net/detail/BIM-1209284

American Medical Association (AMA)

Qiu, Xianjian& Wang, Xudong& Qiu, Jincheng& Zhu, Yuanxin& Liang, Tongzhou& Gao, Bo…[et al.]. Melatonin Rescued Reactive Oxygen Species-Impaired Osteogenesis of Human Bone Marrow Mesenchymal Stem Cells in the Presence of Tumor Necrosis Factor-Alpha. Stem Cells International. 2019. Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1209284

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1209284